Matthew D Perry's Net Worth
$1.92 Million
Who is Matthew D Perry?
Matthew D Perry has an estimated net worth of $1.92 Million. This is based on reported shares across multiple companies, which include XOMA Corp, CTI BIOPHARMA CORP, and AVIGEN INC \DE.
SEC CIK
Matthew D Perry's CIK is 0001454337
Past Insider Trading and Trends
2017 was Matthew D Perry's most active year for acquiring shares with 5 total transactions. Matthew D Perry's most active month to acquire stocks was the month of April. 2023 was Matthew D Perry's most active year for disposing of shares, totalling 7 transactions. Matthew D Perry's most active month to dispose stocks was the month of May. 2020 saw Matthew D Perry paying a total of $5,000,000.00 for 206,152 shares, this is the most they've acquired in one year. In 2023 Matthew D Perry cashed out on 513,139 shares for a total of $392,564.90, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
XOMA Corp (XOMA) Snapshot price: $28.4
InvestorMatthew D Perry owns 11,799 units of Common Stock, $0.0075 par value per share which is worth $335,091.60, 200,000 units of 8.625% Series A Cumulative Perpetual Preferred Stock which is worth $5,680,000.00 and 17,869 units of Common Stock which is worth $507,479.60. From 2017 to 2024 Matthew D Perry acquired a total of 217,869 shares in XOMA Corp at a cost of $5,000,000.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +51.45% | 6.07K |
—
|
—
| 17.87K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
∞
| 200K |
$25.00 | $5,000,000.00 | 200K |
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
∞
| 11.8K |
—
|
—
| 11.8K |
Mar 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CTI BIOPHARMA CORP No price found
InvestorMatthew D Perry used to own units in Common Stock but no longer holds any shares there. In the year 2016 Matthew D Perry filed a total of 12 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -43.14K |
$9.10 | -$392,564.90 |
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
| +413.38% | 34.74K |
—
|
—
| 43.14K |
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
∞
| 8.4K |
—
|
—
| 8.4K |
Jan 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVIGEN INC \DE No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||